Malignant Mesothelioma - Market Insights, Epidemiology & Forecasts - 2023 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Malignant Mesothelioma - Market Insights, Epidemiology and Market Forecast - 2023 - EU5" drug pipelines to their offering.

Malignant mesothelioma is a deadly and rare form of cancer that affects the thin lining known as the mesothelium. Mesothelioma helps to protect the organs by making a special lubricating fluid that allows organs to move against each other. Malignant mesothelioma is a rare, asbestos-related cancer that forms on the thin protective tissues that cover the lungs and abdomen. It is a deadly disease as its prognosis is poor and the survival time after diagnosis is around 9-12 months.

Based on the organ which is first affected, mesothelioma can be divided into several categories:

  • Pleural Mesothelioma: It affects lining of lungs. It is the most common type of mesothelioma and is caused by the inhalation of asbestos fibers. About 70% of the mesothelioma cases fall under this category.
  • Peritoneal Mesothelioma: It affects the lining of abdomen. About 15-20 % cases of mesothelioma are diagnosed as peritoneal.
  • Pericardial Mesothelioma: It affects the lining of heart. Asbestos fibers can get lodged in the pericardium which is the lining around the heart cavity. It's a rare kind of mesothelioma which occurs in 1 % or less number of cases.
  • Tunic vaginalis: It affects the testicles. This is also a rare kind of mesothelioma.

Scope of the Report:

  • Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details.
  • The report also covers the detailed global historical and forecasted epidemiological data covering 7MM from 2010-2023.
  • It also provides Market size of Malignant mesothelioma for 7MM from 2010 and forecasted Market size to 2023.

Key Topics Covered:

  1. Report Introduction
  2. Malignant mesothelioma Market Overview at a Glance
  3. Total Market Size of Malignant mesothelioma for 7 MM in 2013-2023
  4. Total Market Share Distribution of Malignant mesothelioma for 7 MM in 2015
  5. Total Market Share Distribution of Malignant mesothelioma for 7 MM in 2023
  6. Overview
  7. Symptoms
  8. Pathophysiology
  9. Staging
  10. Diagnosis
  11. Treatment
  12. Epidemiology and Patient Population
  13. Diagnosed Cases of Malignant mesothelioma in United States
  14. Diagnosed Cases of Malignant mesothelioma in Germany
  15. Diagnosed Cases of Malignant mesothelioma in France
  16. Diagnosed Cases of Malignant mesothelioma in United Kingdom
  17. Diagnosed Cases of Malignant mesothelioma in Spain
  18. Diagnosed Cases of Malignant mesothelioma in Italy
  19. Diagnosed Cases of Malignant mesothelioma in Japan
  20. Top Marketed Drugs for Malignant mesothelioma
  21. Market Drivers
  22. Market Restraints
  23. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/35pk8x/malignant

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Oncology Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Oncology Drugs